Video_Dr. Jhaveri_mBC_Estabilishing the Unmet Needs for Patients with ESR1 Mutations
In this video, Dr. Komal Jhaveri reviews the mechanisms leading to resistance to standard-of-care therapies for patients with HR-positive, HER2-negative metastatic breast cancer and highlights the potential value of novel, newer endocrine targets.
Date of Last Review: March 06, 2025
Document Number: VV-MED-163411
Please rate your satisfaction with the content on the following statements:
Very Dissatisfied
Dissatisfied
Neutral
Satisfied
Very Satisfied
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice
Please rate your satisfaction with the content on the following statements:
Credibility of information
Relevance of the information to my needs
Confidence to implement the learnings in my clinical practice